INTEC PHARMA LTD. General and Administrative Expense
INTEC PHARMA LTD. reported General and Administrative Expense of $2.02 million for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-17.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GeneralAndAdministrativeExpense · last filed 2021-05-17
- INTEC PHARMA LTD. general and administrative expense for the quarter ending 2021-03-31 was $2.02M, a 17.84% increase year-over-year.
- INTEC PHARMA LTD. general and administrative expense for the quarter ending 2020-12-31 was $2.21M, a 23.33% increase year-over-year.
- INTEC PHARMA LTD. general and administrative expense for the quarter ending 2020-09-30 was $1.53M, a 29.11% decline year-over-year.
- INTEC PHARMA LTD. general and administrative expense for the quarter ending 2020-06-30 was $1.63M, a 23.97% decline year-over-year.
- INTEC PHARMA LTD. general and administrative expense for fiscal 2020 was $7.09M, a 14.46% decline from fiscal 2019.
- INTEC PHARMA LTD. general and administrative expense for fiscal 2019 was $8.29M, a 4.55% increase from fiscal 2018.
- INTEC PHARMA LTD. general and administrative expense for fiscal 2018 was $7.93M, a 54.08% increase from fiscal 2017.
- INTEC PHARMA LTD. general and administrative expense for fiscal 2017 was $5.14M.
| Period end | General and Administrative Expense 3 month | General and Administrative Expense 6 month | General and Administrative Expense 9 month | General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2021-03-31 | $2.02M 10-Q · filed 2021-05-17 | $4.24M derived: sum of 2 quarters · filed 2021-05-17 | $5.76M derived: sum of 3 quarters · filed 2021-05-17 | $7.39M derived: sum of 4 quarters · filed 2021-05-17 |
| 2020-12-31 | $2.21M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $3.74M derived: sum of 2 quarters · filed 2021-03-16 | $5.37M derived: sum of 3 quarters · filed 2021-03-16 | $7.09M 10-K · filed 2021-03-16 |
| 2020-09-30 | $1.53M 10-Q · filed 2020-11-05 | $3.16M derived: sum of 2 quarters · filed 2020-11-05 | $4.87M 10-Q · filed 2020-11-05 | $6.67M derived: sum of 4 quarters · filed 2021-05-17 |
| 2020-06-30 | $1.63M 10-Q · filed 2020-08-05 | $3.35M 10-Q · filed 2020-08-05 | $5.14M derived: sum of 3 quarters · filed 2021-05-17 | $7.30M derived: sum of 4 quarters · filed 2021-05-17 |
| 2020-03-31 | $1.72M 10-Q · filed 2021-05-17 | $3.51M derived: sum of 2 quarters · filed 2021-05-17 | $5.67M derived: sum of 3 quarters · filed 2021-05-17 | $7.81M derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | $1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $3.95M derived: sum of 2 quarters · filed 2021-03-16 | $6.10M derived: sum of 3 quarters · filed 2021-03-16 | $8.29M 10-K · filed 2021-03-16 |
| 2019-09-30 | $2.16M 10-Q · filed 2020-11-05 | $4.30M derived: sum of 2 quarters · filed 2020-11-05 | $6.49M 10-Q · filed 2020-11-05 | $8.62M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $2.14M 10-Q · filed 2020-08-05 | $4.33M 10-Q · filed 2020-08-05 | $6.46M derived: sum of 3 quarters · filed 2020-08-05 | $8.16M derived: sum of 4 quarters · filed 2020-08-05 |
| 2019-03-31 | $2.19M 10-Q · filed 2020-05-11 | $4.32M derived: sum of 2 quarters · filed 2020-05-11 | $6.01M derived: sum of 3 quarters · filed 2020-05-11 | $8.21M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $2.13M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $3.82M derived: sum of 2 quarters · filed 2020-03-13 | $6.02M derived: sum of 3 quarters · filed 2020-03-13 | $7.93M 10-K · filed 2020-03-13 |
| 2018-09-30 | $1.70M 10-Q · filed 2019-11-12 | $3.89M derived: sum of 2 quarters · filed 2019-11-12 | $5.80M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $2.19M 10-Q · filed 2019-08-09 | $4.10M 10-Q · filed 2019-08-09 | ||
| 2018-03-31 | $1.91M 10-Q · filed 2019-05-07 | |||
| 2017-12-31 | $5.14M 10-K · filed 2019-02-27 |